Publication | Closed Access

Comparable efficacy and lower cost of PBSC mobilization with intermediate-dose cyclophosphamide and G-CSF compared with plerixafor and G-CSF in patients with multiple myeloma treated with novel therapies

Hematological MalignancyOncologyPbsc MobilizationMetronomic TherapyImmunologyHematologyNovel TherapiesMultiple MyelomaPharmacotherapyMedicine